3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
3
Neuralgia
3
Breast Neoplasms
3
Seizures
1
Pinealoma
1
Oligodendroglioma
1
Obesity
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Myotoxicity
1
Meningioma
1
Medulloblastoma
1
Lymphoma
1
Inflammation
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Ependymoma
1
Earache
1
Drug-Related Side Effects and Adverse Reactions
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Agnosia
1
Interventions
Pregabalin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Earache
×
Pregabalin
×
Clear all
NCT02924675
2019-10-14
LYRORL
University Hospital, Lille
Phase 2
Terminated
42 enrolled